76 related articles for article (PubMed ID: 26661780)
1. New approaches for characterization of the genetic stability of vaccine cell lines.
Ng S; Gisonni-Lex L; Azizi A
Hum Vaccin Immunother; 2017 Jul; 13(7):1669-1672. PubMed ID: 28333573
[TBL] [Abstract][Full Text] [Related]
2. Plant-based vaccines for animals and humans: recent advances in technology and clinical trials.
Takeyama N; Kiyono H; Yuki Y
Ther Adv Vaccines; 2015 Sep; 3(5-6):139-54. PubMed ID: 26668752
[TBL] [Abstract][Full Text] [Related]
3. MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system.
Yuki Y; Kurokawa S; Sugiura K; Kashima K; Maruyama S; Yamanoue T; Honma A; Mejima M; Takeyama N; Kuroda M; Kozuka-Hata H; Oyama M; Masumura T; Nakahashi-Ouchida R; Fujihashi K; Hiraizumi T; Goto E; Kiyono H
Front Plant Sci; 2024; 15():1342662. PubMed ID: 38559768
[TBL] [Abstract][Full Text] [Related]
4. Production and
Nguyen KD; Kajiura H; Kamiya R; Yoshida T; Misaki R; Fujiyama K
Front Plant Sci; 2023; 14():1215580. PubMed ID: 37615027
[No Abstract] [Full Text] [Related]
5. Rice-produced classical swine fever virus glycoprotein E2 with herringbone-dimer design to enhance immune responses.
Xu Q; Ma F; Yang D; Li Q; Yan L; Ou J; Zhang L; Liu Y; Zhan Q; Li R; Wei Q; Hu H; Wang Y; Li X; Zhang S; Yang J; Chai S; Du Y; Wang L; Zhang E; Zhang G
Plant Biotechnol J; 2023 Dec; 21(12):2546-2559. PubMed ID: 37572354
[TBL] [Abstract][Full Text] [Related]
6. Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines.
Maharjan PM; Choe S
Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579229
[TBL] [Abstract][Full Text] [Related]
7. Mucosal vaccines: wisdom from now and then.
Kiyono H; Yuki Y; Nakahashi-Ouchida R; Fujihashi K
Int Immunol; 2021 Nov; 33(12):767-774. PubMed ID: 34436595
[TBL] [Abstract][Full Text] [Related]
8. Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.
He W; Baysal C; Lobato Gómez M; Huang X; Alvarez D; Zhu C; Armario-Najera V; Blanco Perera A; Cerda Bennaser P; Saba-Mayoral A; Sobrino-Mengual G; Vargheese A; Abranches R; Alexandra Abreu I; Balamurugan S; Bock R; Buyel JF; da Cunha NB; Daniell H; Faller R; Folgado A; Gowtham I; Häkkinen ST; Kumar S; Sathish Kumar R; Lacorte C; Lomonossoff GP; Luís IM; K-C Ma J; McDonald KA; Murad A; Nandi S; O'Keef B; Parthiban S; Paul MJ; Ponndorf D; Rech E; Rodrigues JCM; Ruf S; Schillberg S; Schwestka J; Shah PS; Singh R; Stoger E; Twyman RM; Varghese IP; Vianna GR; Webster G; Wilbers RHP; Christou P; Oksman-Caldentey KM; Capell T
Plant Biotechnol J; 2021 Oct; 19(10):1921-1936. PubMed ID: 34181810
[TBL] [Abstract][Full Text] [Related]
9. Comparative whole-genome and proteomics analyses of the next seed bank and the original master seed bank of MucoRice-CTB 51A line, a rice-based oral cholera vaccine.
Sasou A; Yuki Y; Honma A; Sugiura K; Kashima K; Kozuka-Hata H; Nojima M; Oyama M; Kurokawa S; Maruyama S; Kuroda M; Tanoue S; Takamatsu N; Fujihashi K; Goto E; Kiyono H
BMC Genomics; 2021 Jan; 22(1):59. PubMed ID: 33468052
[TBL] [Abstract][Full Text] [Related]
10. Development of Systems for the Production of Plant-Derived Biopharmaceuticals.
Moon KB; Park JS; Park YI; Song IJ; Lee HJ; Cho HS; Jeon JH; Kim HS
Plants (Basel); 2019 Dec; 9(1):. PubMed ID: 31878277
[TBL] [Abstract][Full Text] [Related]
11. A Fruitful Decade Using Synthetic Promoters in the Improvement of Transgenic Plants.
Ali S; Kim WC
Front Plant Sci; 2019; 10():1433. PubMed ID: 31737027
[TBL] [Abstract][Full Text] [Related]
12. Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines.
Criscuolo E; Caputo V; Diotti RA; Sautto GA; Kirchenbaum GA; Clementi N
J Immunol Res; 2019; 2019():8303648. PubMed ID: 30949518
[TBL] [Abstract][Full Text] [Related]
13. Seed Metabolome Analysis of a Transgenic Rice Line Expressing Cholera Toxin B-subunit.
Ogawa T; Kashima K; Yuki Y; Mejima M; Kurokawa S; Kuroda M; Okazawa A; Kiyono H; Ohta D
Sci Rep; 2017 Jul; 7(1):5196. PubMed ID: 28701756
[TBL] [Abstract][Full Text] [Related]
14. Corn-based vaccines: current status and prospects.
Rosales-Mendoza S; Sández-Robledo C; Bañuelos-Hernández B; Angulo C
Planta; 2017 May; 245(5):875-888. PubMed ID: 28349257
[TBL] [Abstract][Full Text] [Related]
15. Oral immunisation of mice with transgenic rice calli expressing cholera toxin B subunit fused to consensus dengue cEDIII antigen induces antibodies to all four dengue serotypes.
Kim MY; Kim BY; Oh SM; Reljic R; Jang YS; Yang MS
Plant Mol Biol; 2016 Oct; 92(3):347-56. PubMed ID: 27566485
[TBL] [Abstract][Full Text] [Related]
16. Edible plants for oral delivery of biopharmaceuticals.
Merlin M; Pezzotti M; Avesani L
Br J Clin Pharmacol; 2017 Jan; 83(1):71-81. PubMed ID: 27037892
[TBL] [Abstract][Full Text] [Related]
17. Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants.
Kashima K; Yuki Y; Mejima M; Kurokawa S; Suzuki Y; Minakawa S; Takeyama N; Fukuyama Y; Azegami T; Tanimoto T; Kuroda M; Tamura M; Gomi Y; Kiyono H
Plant Cell Rep; 2016 Mar; 35(3):667-79. PubMed ID: 26661780
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
